

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Advancing understanding, diagnosis, and therapies... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-332/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-332" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus" />
    
            <meta name="og:title" content="F1000Research Article: Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.">
            <meta name="og:description" content="Read the latest article version by Kristen L. Chen, Rebecca L. Krain, Victoria P.  Werth, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="19447">
            <meta name="article-id" content="17787">
            <meta name="dc.title" content="Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus">
            <meta name="dc.description" content="Cutaneous lupus erythematosus (CLE) is an autoimmune disease that can be associated with systemic lupus erythematosus (SLE) symptoms. The pathogenesis of both CLE and SLE is multifactorial, involving genetic susceptibility, environmental factors, and innate and adaptive immune responses. Despite the efficacy of current medications, many patients remain refractory, highlighting the necessity for new treatment options. Unfortunately, owing to challenges related in part to trial design and disease heterogeneity, only one new biologic in the last 50 years has been approved by the US Food and Drug Administration for the treatment of SLE. Thus, although SLE and CLE have a similar pathogenesis, patients with CLE who do not meet criteria for SLE cannot benefit from this advancement. This article discusses the recent trials and emphasizes the need to include patients with single-organ lupus, such as CLE, in SLE trials.">
            <meta name="dc.subject" content="cutaneous lupus erythematosus, systemic lupus erythematosus, clinical trials  ">
            <meta name="dc.creator" content="Chen, Kristen L.">
            <meta name="dc.creator" content="Krain, Rebecca L.">
            <meta name="dc.creator" content="Werth, Victoria P. ">
            <meta name="dc.date" content="2019/03/25">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.17787.1">
            <meta name="dc.source" content="F1000Research 2019 8:332">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="cutaneous lupus erythematosus">
            <meta name="prism.keyword" content="systemic lupus erythematosus">
            <meta name="prism.keyword" content="clinical trials  ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/03/25">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="332">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.17787.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-332">
            <meta name="citation_title" content="Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus">
            <meta name="citation_abstract" content="Cutaneous lupus erythematosus (CLE) is an autoimmune disease that can be associated with systemic lupus erythematosus (SLE) symptoms. The pathogenesis of both CLE and SLE is multifactorial, involving genetic susceptibility, environmental factors, and innate and adaptive immune responses. Despite the efficacy of current medications, many patients remain refractory, highlighting the necessity for new treatment options. Unfortunately, owing to challenges related in part to trial design and disease heterogeneity, only one new biologic in the last 50 years has been approved by the US Food and Drug Administration for the treatment of SLE. Thus, although SLE and CLE have a similar pathogenesis, patients with CLE who do not meet criteria for SLE cannot benefit from this advancement. This article discusses the recent trials and emphasizes the need to include patients with single-organ lupus, such as CLE, in SLE trials.">
            <meta name="citation_description" content="Cutaneous lupus erythematosus (CLE) is an autoimmune disease that can be associated with systemic lupus erythematosus (SLE) symptoms. The pathogenesis of both CLE and SLE is multifactorial, involving genetic susceptibility, environmental factors, and innate and adaptive immune responses. Despite the efficacy of current medications, many patients remain refractory, highlighting the necessity for new treatment options. Unfortunately, owing to challenges related in part to trial design and disease heterogeneity, only one new biologic in the last 50 years has been approved by the US Food and Drug Administration for the treatment of SLE. Thus, although SLE and CLE have a similar pathogenesis, patients with CLE who do not meet criteria for SLE cannot benefit from this advancement. This article discusses the recent trials and emphasizes the need to include patients with single-organ lupus, such as CLE, in SLE trials.">
            <meta name="citation_keywords" content="cutaneous lupus erythematosus, systemic lupus erythematosus, clinical trials  ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Kristen L. Chen">
            <meta name="citation_author_institution" content="Department of Dermatology, Corporal Michael J. Crescenz VAMC, 3900 Woodland Avenue, Philadelphia, PA 19104, USA">
            <meta name="citation_author_institution" content="Department of Dermatology, Perelman Center for Advanced Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Suite 1-330A, Philadelphia, PA 19104, USA">
            <meta name="citation_author" content="Rebecca L. Krain">
            <meta name="citation_author_institution" content="Department of Dermatology, Corporal Michael J. Crescenz VAMC, 3900 Woodland Avenue, Philadelphia, PA 19104, USA">
            <meta name="citation_author_institution" content="Department of Dermatology, Perelman Center for Advanced Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Suite 1-330A, Philadelphia, PA 19104, USA">
            <meta name="citation_author" content="Victoria P.  Werth">
            <meta name="citation_author_institution" content="Department of Dermatology, Corporal Michael J. Crescenz VAMC, 3900 Woodland Avenue, Philadelphia, PA 19104, USA">
            <meta name="citation_author_institution" content="Department of Dermatology, Perelman Center for Advanced Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Suite 1-330A, Philadelphia, PA 19104, USA">
            <meta name="citation_publication_date" content="2019/03/25">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="332">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.17787.1">
            <meta name="citation_firstpage" content="332">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-332/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-332.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=19447 /> <input type=hidden id=articleId name=articleId value=17787 /> <input type=hidden id=xmlUrl value="/articles/8-332/v1/xml"/> <input type=hidden id=xmlFileName value="-8-332-v1.xml"> <input type=hidden id=article_uuid value=28d2c437-8ab1-4c78-881b-d125911b21c3 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.17787.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.17787.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-332"
  },
  "headline": "Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context...",
  "datePublished": "2019-03-25T12:04:27",
  "dateModified": "2019-03-25T12:04:27",
  "author": [
    {
      "@type": "Person",
      "name": "Kristen L. Chen"
    },    {
      "@type": "Person",
      "name": "Rebecca L. Krain"
    },    {
      "@type": "Person",
      "name": "Victoria P.  Werth"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Cutaneous lupus erythematosus (CLE) is an autoimmune disease that can be associated with systemic lupus erythematosus (SLE) symptoms. The pathogenesis of both CLE and SLE is multifactorial, involving genetic susceptibility, environmental factors, and innate and adaptive immune responses. Despite the efficacy of current medications, many patients remain refractory, highlighting the necessity for new treatment options. Unfortunately, owing to challenges related in part to trial design and disease heterogeneity, only one new biologic in the last 50 years has been approved by the US Food and Drug Administration for the treatment of SLE. Thus, although SLE and CLE have a similar pathogenesis, patients with CLE who do not meet criteria for SLE cannot benefit from this advancement. This article discusses the recent trials and emphasizes the need to include patients with single-organ lupus, such as CLE, in SLE trials."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-332.html",
            "name": "Advancing understanding, diagnosis, and therapies for cutaneous lupus..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Advancing understanding, diagnosis, and therapies for cutaneous lupus... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=19447 data-id=17787 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17787.1" data-recommended="" data-doi="10.12688/f1000research.17787.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-332/v1/pdf?article_uuid=28d2c437-8ab1-4c78-881b-d125911b21c3" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-17787-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-17787-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-17787-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Chen KL, Krain RL and Werth VP. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):332 (<a class=new-orange href="https://doi.org/10.12688/f1000research.17787.1" target=_blank>https://doi.org/10.12688/f1000research.17787.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-17787-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=17787 id=track-article-signin-17787 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17787?target=/articles/8-332.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=19447 /> <input name=articleId type=hidden value=17787 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Kristen L. Chen<a href="https://orcid.org/0000-0002-0361-9234" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0361-9234</div><sup>1,2</sup>,&nbsp;</span><span class="">Rebecca L. Krain<sup>1,2</sup>,&nbsp;</span><span class=""><a href="mailto:werth@pennmedicine.upenn.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Victoria P. Werth</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Kristen L. Chen<a href="http://orcid.org/0000-0002-0361-9234" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0361-9234</div><sup>1,2</sup>,&nbsp;</span><span class="">Rebecca L. Krain<sup>1,2</sup>,&nbsp;</span><span class=""><a href="mailto:werth@pennmedicine.upenn.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Victoria P. Werth</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 25 Mar 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.17787.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Dermatology, Corporal Michael J. Crescenz VAMC, 3900 Woodland Avenue, Philadelphia, PA 19104, USA<br/> <sup>2</sup> Department of Dermatology, Perelman Center for Advanced Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Suite 1-330A, Philadelphia, PA 19104, USA<br/> <p> <div class=margin-bottom> Kristen L. Chen <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Rebecca L. Krain <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Victoria P. Werth <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Supervision, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=47924-45932></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=47923-45927></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=47925-45931></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Cutaneous lupus erythematosus (CLE) is an autoimmune disease that can be associated with systemic lupus erythematosus (SLE) symptoms. The pathogenesis of both CLE and SLE is multifactorial, involving genetic susceptibility, environmental factors, and innate and adaptive immune responses. Despite the efficacy of current medications, many patients remain refractory, highlighting the necessity for new treatment options. Unfortunately, owing to challenges related in part to trial design and disease heterogeneity, only one new biologic in the last 50 years has been approved by the US Food and Drug Administration for the treatment of SLE. Thus, although SLE and CLE have a similar pathogenesis, patients with CLE who do not meet criteria for SLE cannot benefit from this advancement. This article discusses the recent trials and emphasizes the need to include patients with single-organ lupus, such as CLE, in SLE trials. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> cutaneous lupus erythematosus, systemic lupus erythematosus, clinical trials </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Victoria P. Werth (<a href="mailto:werth@pennmedicine.upenn.edu">werth@pennmedicine.upenn.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Victoria P. Werth </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors are employed by the University of Pennsylvania, which owns the copyright for the CLASI. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This project is supported by the Department of Veterans Affairs Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development and National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) R01AR071653 (VPW). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Chen KL <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Chen KL, Krain RL and Werth VP. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):332 (<a href="https://doi.org/10.12688/f1000research.17787.1" target=_blank>https://doi.org/10.12688/f1000research.17787.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 25 Mar 2019, <b>8</b>(F1000 Faculty Rev):332 (<a href="https://doi.org/10.12688/f1000research.17787.1" target=_blank>https://doi.org/10.12688/f1000research.17787.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 25 Mar 2019, <b>8</b>(F1000 Faculty Rev):332 (<a href="https://doi.org/10.12688/f1000research.17787.1" target=_blank>https://doi.org/10.12688/f1000research.17787.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d17615e185>Introduction</h2><p class="" id=d17615e188>Lupus erythematosus (LE) is an autoimmune disease associated with a broad range of cutaneous LE (CLE) and systemic LE (SLE) symptoms<sup><a href="#ref-1">1</a></sup>. In the US and Europe, the incidence of CLE approximates that of SLE, ranging from 2.0 to 7.6 cases per 100,000 persons per year<sup><a href="#ref-2">2</a>–<a href="#ref-5">5</a></sup>. CLE is divided into three primary subsets: acute CLE, subacute CLE (SCLE), and chronic CLE<sup><a href="#ref-6">6</a></sup>. Chronic CLE is subsequently categorized as discoid LE (DLE), hypertrophic LE, LE profundus, chilblain CLE, and lupus tumidus<sup><a href="#ref-6">6</a></sup>. As suggested by these varied subtypes in CLE alone, lupus is a heterogeneous disease, making diagnosis and treatment challenging in some cases. Patients may be recalcitrant to first- and second-line therapies, underscoring the necessity for new treatments. This review will briefly touch on developments in CLE diagnostic criteria, pathogenesis, current treatment options, and challenges faced in drug trials. We will discuss findings in the most recent therapeutic trials for SLE and highlight the need to include patients with isolated cutaneous symptoms who do not meet criteria for SLE.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17615e213>Diagnostic criteria</h2><p class="" id=d17615e216>Whereas SLE criteria have been defined, debated, and revised, the development of CLE criteria is just beginning. The American College of Rheumatology<sup><a href="#ref-7">7</a></sup> and the Systemic Lupus International Collaborating Clinics<sup><a href="#ref-8">8</a></sup> have developed two different classification criteria for SLE. However, both exclude many patients with single-organ lupus (that is, CLE) who have moderate to severe manifestations<sup><a href="#ref-9">9</a></sup>. In 2013, the 3rd International Meeting on Cutaneous Lupus Erythematosus began a process to achieve consensus on uniform definitions, diagnostic criteria, and classification of CLE<sup><a href="#ref-10">10</a></sup>. Having agreed upon the Delphi consensus method, in which a series of iterative questionnaires are anonymously completed by selected experts, international experts analyzed a “pre-Delphi” questionnaire<sup><a href="#ref-11">11</a></sup>. They reported a need for a new CLE definition to improve communication of prognostic information and delineate study populations for both observational and interventional trials<sup><a href="#ref-11">11</a></sup>. Most recently, the Delphi method was used to begin developing criteria for diagnosing DLE as part of a larger effort to define CLE<sup><a href="#ref-12">12</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17615e251>Pathogenesis</h2><p class="" id=d17615e254>The pathogenesis of CLE remains incompletely understood but is multifactorial, involving genetic polymorphisms, susceptibility loci, environmental factors such as ultraviolet (UV) exposure and smoking, and the induction of innate and adaptive immune responses<sup><a href="#ref-13">13</a></sup>. T lymphocytes are the predominant cells in CLE; however, plasmacytoid and myeloid dendritic cells (pDCs and mDCs, respectively) play an essential role in disease pathogenesis<sup><a href="#ref-14">14</a></sup>. Type 1 interferons (IFNs), which are produced largely by dendritic cells and keratinocytes, are critical to the development of CLE lesions and are produced in response to UV light, nuclear antigens, and immune complexes<sup><a href="#ref-15">15</a>–<a href="#ref-17">17</a></sup>. They initiate a cycle of cutaneous inflammation by recruiting leukocytes to the skin via inflammatory cytokines, chemokines, and adhesion molecules<sup><a href="#ref-15">15</a></sup>. An IFN signature is present in SLE and the CLE subtypes SCLE and DLE, suggesting a shared pathogenesis<sup><a href="#ref-18">18</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17615e283>Current treatment options</h2><p class="" id=d17615e286>There are several current treatment options for CLE, and antimalarials (that is, hydroxychloroquine, chloroquine, and quinacrine) are considered first-line therapy. About 75% of patients with CLE respond to antimalarial therapy or topical glucocorticoids or both<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. Antimalarials act via immunomodulating effects by influencing antigen presentation, stabilizing lysosomes, inhibiting Toll-like receptor signaling, and reducing IFN production by pDCs<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>. In particular, quinacrine suppresses the Toll receptor–mediated production of tumor necrosis factor-α likely produced by mDC populations<sup><a href="#ref-14">14</a>,<a href="#ref-23">23</a></sup>. Owing to the variation in cutaneous response, antimalarials are frequently used in combination for refractory CLE<sup><a href="#ref-24">24</a></sup>. However, should patients remain resistant to antimalarial therapy, immunosuppressives (that is, methotrexate, mycophenolate mofetil, and azathioprine) may be used. Mycophenolate mofetil and mycophenolate sodium have been shown to be highly effective and well tolerated in cases of antimalarial-resistant CLE<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>. When methotrexate was compared with chloroquine in the treatment of cutaneous manifestations of SLE, low-dose methotrexate was determined to be as effective as chloroquine and to have an acceptable toxicity profile<sup><a href="#ref-27">27</a></sup>. Thalidomide is another therapy used in antimalarial-refractory CLE. It is an anti-inflammatory agent and immunomodulator that targets cereblon, reducing the zinc finger transcription factors Aiolos and Ikaros and consequently modulating T-cell function<sup><a href="#ref-28">28</a></sup>. It has been shown to be efficacious in treating refractory cutaneous interface manifestations of LE<sup><a href="#ref-29">29</a></sup>. However, owing to the high risk of polyneuropathy and teratogenicity, thalidomide should be reserved for cases of severely refractory CLE and used at low doses and as short-term therapy<sup><a href="#ref-29">29</a>–<a href="#ref-31">31</a></sup>. More recently, lenalidomide, a thalidomide analog, has gained traction as a useful therapy in patients who remain recalcitrant to antimalarials or thalidomide<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. It has been shown to be efficacious and safe and importantly does not cause as much peripheral neuropathy<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. Despite this, caution should be taken in women of childbearing age as to date there is no evidence demonstrating safety in human fetal development. In summary, the main current therapies for CLE include antimalarials, glucocorticoids, immunosuppressives, thalidomide, and lenalidomide, which typically provide symptom relief.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17615e358>Challenges in trial design</h2><p class="" id=d17615e361>Although current treatment for CLE has been effective, some patients remain refractory to treatment or require less toxic therapies or do both. There is a need for safe and effective therapies for these refractory patients. Despite this, no medications have been approved for CLE in over 50 years; this is largely due to problems associated with lupus trial design<sup><a href="#ref-35">35</a></sup>. In a recent proposal for optimizing lupus clinical trials, Merrill <i>et al.</i> highlighted challenges to developing new treatments<sup><a href="#ref-9">9</a></sup>. These include the heterogeneity of lupus itself, the influence of a wide variety of background therapies, the scarcity of patients meeting stringent enrollment criteria, and the limited number of properly equipped trial sites<sup><a href="#ref-9">9</a></sup>. However, the development of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) has made it easier to evaluate treatment for CLE, and within the past few years several clinical studies and trials using this tool have shown promising results<sup><a href="#ref-25">25</a>,<a href="#ref-36">36</a>–<a href="#ref-46">46</a></sup>. Recently, an international group of dermatologists unanimously agreed that the CLASI be used in clinical trials as a measure of skin activity<sup><a href="#ref-47">47</a></sup>. Still, with regard to the progress of new therapeutics, only anifrolumab and baricitinib have recently entered into phase III, and many of the remainder failed to meet critical endpoints.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17615e398>Recent drug trials</h2><div class=section><a name=d17615e401 class=n-a></a><h3 class=section-title>Belimumab</h3><p class="" id=d17615e406>Belimumab is a monoclonal antibody directed against B-lymphocyte stimulator (BLyS), an immunomodulatory cytokine that stimulates B-cell differentiation and survival<sup><a href="#ref-48">48</a></sup>. A multicenter, randomized, controlled, phase III trial assessed the safety and efficacy of this medication, comparing belimumab plus standard therapy with placebo plus standard therapy in patients with SLE<sup><a href="#ref-49">49</a></sup>. In this study, belimumab decreased the number of flares and hindered damage progression in patients with SLE<sup><a href="#ref-40">40</a>,<a href="#ref-49">49</a></sup>. Belimumab was also found to improve cutaneous disease, such as rash, mucosal ulcers, and alopecia, and patients with musculoskeletal and skin manifestations responded best to this medication<sup><a href="#ref-40">40</a>,<a href="#ref-50">50</a></sup>. Despite this, belimumab is US Food and Drug Administration (FDA)-approved solely for the treatment of SLE, as clinical trials did not formally study the effects of the drug on cutaneous disease<sup><a href="#ref-51">51</a></sup>. As a result, patients with CLE struggle to access this medication despite its possible efficacy and tolerability for a subset of patients.</p></div><div class=section><a name=d17615e436 class=n-a></a><h3 class=section-title>Sifalimumab and anifrolumab</h3><p class="" id=d17615e441>Sifalimumab, an anti-IFN-α monoclonal antibody, was assessed in SLE patients with moderate to severe disease in a phase IIb, randomized, double-blind, placebo-controlled study. The percentage of patients with improvements in CLASI was greater for all sifalimumab doses compared with the placebo, although <i>Herpes zoster</i> infections were more frequent with sifalimumab treatment<sup><a href="#ref-41">41</a>,<a href="#ref-48">48</a></sup>. Despite such promising results, this trial was discontinued to further assess anifrolumab, an anti-IFN-α receptor monoclonal antibody that binds the type I IFN-α/β/ω receptor (IFNAR), preventing signaling by all type I IFNs<sup><a href="#ref-42">42</a></sup>. In a phase IIb, randomized, double-blind, placebo-controlled study of anifrolumab, as in the study of sifalimumab, a greater percentage of patients showed significant improvement in their cutaneous activity as compared with the placebo group, and more of an effect was seen in patients with higher baseline IFN levels<sup><a href="#ref-42">42</a>,<a href="#ref-48">48</a></sup>. Although <i>Herpes zoster</i> infections were reported in 5.1% and 9.5% of the patients receiving 300 mg and 1,000 mg of anifrolumab, respectively, the most common adverse events included headache, upper respiratory infection, nasopharyngitis, and urinary tract infection<sup><a href="#ref-42">42</a></sup>. The success of this clinical trial led to two phase III studies, and the results have yet to be published. Thus far, findings from both sifalimumab and anifrolumab phase II trials have collectively demonstrated a role of many type I IFNs in patients with SLE.</p></div><div class=section><a name=d17615e474 class=n-a></a><h3 class=section-title>Baricitinib</h3><p class="" id=d17615e479>In a double-blind, multicenter, randomized, placebo-controlled phase II study, baricitinib, a Janus kinase 1 (JAK1) and JAK2 inhibitor, was assessed<sup><a href="#ref-43">43</a></sup>. JAKs are tyrosine kinases that mediate the signaling of several pro-inflammatory cytokines, most of which have been found to be associated with the pathogenesis of SLE<sup><a href="#ref-43">43</a></sup>. Although a large number of patients presented with merely mild cutaneous disease, the larger dose of baricitinib (4 mg) significantly improved the signs and symptoms of SLE, especially arthritis<sup><a href="#ref-43">43</a></sup>. As expected, serious adverse events were more common with the 2 mg and 4 mg doses of baricitinib than the placebo (10%, 10%, and 5%, respectively); however, no deaths, malignancies, or major adverse cardiovascular events were noted, making baricitinib a rather safe and tolerable oral medication<sup><a href="#ref-43">43</a></sup>. As baricitinib is a potential medication for patients with cutaneous disease, further studies are needed to better understand its possible effect on skin activity; it is recommended patients be enrolled when they present with moderate to severe skin disease so that changes in skin activity can be better noted.</p></div><div class=section><a name=d17615e499 class=n-a></a><h3 class=section-title>Emerging therapies</h3><p class="" id=d17615e504>Several recent and upcoming clinical trials have been successful in showing an improvement in cutaneous disease in patients with SLE. BIIB059, an anti-BDCA2 monoclonal antibody, is being studied. The antibody, when bound, leads to internalization of BDCA2, a pDC-specific receptor, and inhibits the production of type I IFNs and other inflammatory mediators<sup><a href="#ref-44">44</a></sup>. This phase Ib randomized, double-blind, placebo-controlled, multicenter clinical trial has not only confirmed the role of pDCs in SLE but has also shown a decrease in cutaneous disease activity in these patients as compared with placebo<sup><a href="#ref-44">44</a></sup>. Because most adverse events are mild to moderate in severity, the results of this study have led to further development of BIIB059.</p><p class="" id=d17615e515>Another therapy, CC-220, is also being studied. Similar to thalidomide and its analogs, CC-220 is a high-affinity ligand for cereblon with immunomodulatory properties; its administration decreases Ikaros and Aiolos, two transcription factors encoded by their respective susceptibility loci, IKZF1 and IKZF3, which are associated with SLE<sup><a href="#ref-45">45</a></sup>. This randomized, double-blind, placebo-controlled, phase IIa dose escalation study showed a strong correlation between improvement in CLASI score and pDC reduction<sup><a href="#ref-45">45</a></sup>. Like BIIB059, CC-220 is being developed further in ongoing studies of SLE patients with skin involvement.</p><p class="" id=d17615e526>Finally, a recent study assessing the safety and tolerability of ustekinumab, an IL-12/23 monoclonal antibody, was performed, as this pathway has also been associated with the pathogenesis of SLE<sup><a href="#ref-46">46</a></sup>. Among the patients with at least mild cutaneous disease in this phase II, placebo-controlled study, a statistically significantly greater percentage of patients saw improvement in skin activity with ustekinumab as compared with placebo<sup><a href="#ref-46">46</a></sup>. Such clinical trials not only advance our knowledge and treatment of CLE but more importantly have the potential to improve these patients’ quality of life.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17615e541>Special considerations for skin drug trials</h2><p class="" id=d17615e544>As these exciting therapies move forward for SLE, we want to underscore the importance of including patients with CLE in these trials and acknowledge special considerations for skin drug trials. Active CLE is associated with a significant impact on quality of life<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup> and therefore is worthy of therapy. Furthermore, skin disease in patients with SLE is associated with greater accrual of damage, including chronic seizures and scarring alopecia<sup><a href="#ref-54">54</a></sup>. Given that the pathogenesis of SLE and CLE is very similar, treatments for SLE should benefit patients with CLE. However, at present, because patients with CLE are often excluded from these trials, efficacious and safe medications, like belimumab, are not FDA-approved for CLE. Thus, patients are not able to easily access medications that have the potential to alleviate the distress and suffering caused by their disease.</p><p class="" id=d17615e558>When considering including patients with CLE, we acknowledge certain challenges associated with skin clinical trials. First, among patients with cutaneous disease who are enrolled in clinical trials to evaluate CLE, those with moderate to severe skin activity should be included. For instance, in the baricitinib trial, it was difficult to show an improvement in skin disease with the medication as most patients presented with relatively mild disease<sup><a href="#ref-43">43</a></sup>. Second, the use of background therapies has led to high placebo response rates. In order to decrease the chances of this occurring, it is recommended that patients with lower placebo response rates, particularly patients with refractory DLE or SCLE, be enrolled in clinical trials, as these patients do not respond well to background medications<sup><a href="#ref-35">35</a></sup>. Notably, however, patients with isolated cutaneous disease generally require fewer background medications compared with patients with multi-organ involvement who may be systemically ill. Given these challenges, recommendations previously put forth include smaller, shorter trials and paring down background therapies when appropriate as well as including more discriminatory endpoints<sup><a href="#ref-9">9</a></sup>. We support these suggestions with the hope that patients affected by CLE may obtain better therapies.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d17615e576>Abbreviations</h2><p class="" id=d17615e579>CLASI, Cutaneous Lupus Erythematosus Disease Area and Severity Index; CLE, cutaneous lupus erythematosus; DLE, discoid lupus erythematosus; FDA, US Food and Drug Administration; IFN, interferon; JAK, Janus kinase; LE, lupus erythematosus; mDC, myeloid dendritic cell; pDC, plasmacytoid dendritic cell; SCLE, subacute cutaneous lupus erythematosus; SLE, systemic lupus erythematosus; UV, ultraviolet</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d17615e1 class=n-a></a><h2 class=main-title id=d17783>Grant information</h2><p>This project is supported by the Department of Veterans Affairs Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development and National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) R01AR071653 (VPW).</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d17615e586 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d17970>References</h2><div class="section ref-list"><a name=d17615e586 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d17615e593 class=n-a></a>Chang J, Werth VP: Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects. <i>Expert Rev Clin Immunol.</i> 2016; <b>12</b>(10): 1109–21. <a target=xrefwindow id=d17615e601 href="http://www.ncbi.nlm.nih.gov/pubmed/27249209">PubMed Abstract </a> | <a target=xrefwindow id=d17615e604 href="https://doi.org/10.1080/1744666X.2016.1188006">Publisher Full Text </a> | <a target=xrefwindow id=d17615e607 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5843480">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d17615e616 class=n-a></a>Jiménez S, Cervera R, Font J, <i> et al.</i>: The epidemiology of systemic lupus erythematosus. <i>Clin Rev Allergy Immunol.</i> 2003; <b>25</b>(1): 3–12. <a target=xrefwindow id=d17615e627 href="http://www.ncbi.nlm.nih.gov/pubmed/12794256">PubMed Abstract </a> | <a target=xrefwindow id=d17615e630 href="https://doi.org/10.1385/CRIAI:25:1:3">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728264989"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d17615e639 class=n-a></a>Jarukitsopa S, Hoganson DD, Crowson CS, <i> et al.</i>: Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. <i>Arthritis Care Res (Hoboken).</i> 2015; <b>67</b>(6): 817–28. <a target=xrefwindow id=d17615e650 href="http://www.ncbi.nlm.nih.gov/pubmed/25369985">PubMed Abstract </a> | <a target=xrefwindow id=d17615e653 href="https://doi.org/10.1002/acr.22502">Publisher Full Text </a> | <a target=xrefwindow id=d17615e657 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4418944">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728264989">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733722796"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d17615e675 class=n-a></a>Petersen MP, Möller S, Bygum A, <i> et al.</i>: Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark. <i>Lupus.</i> 2018; <b>27</b>(9): 1424–30. <a target=xrefwindow id=d17615e686 href="http://www.ncbi.nlm.nih.gov/pubmed/29788808">PubMed Abstract </a> | <a target=xrefwindow id=d17615e689 href="https://doi.org/10.1177/0961203318777103">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733722796">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724197371"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e707 class=n-a></a>Gronhagen CM, Fored CM, Granath F, <i> et al.</i>: Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. <i>Br J Dermatol.</i> 2011; <b>154</b>(5): 1335–41. <a target=xrefwindow id=d17615e718 href="http://www.ncbi.nlm.nih.gov/pubmed/21574972">PubMed Abstract </a> | <a target=xrefwindow id=d17615e721 href="https://doi.org/10.1111/j.1365-2133.2011.10272.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724197371">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d17615e735 class=n-a></a>Okon LG, Werth VP: Cutaneous lupus erythematosus: diagnosis and treatment. <i>Best Pract Res Clin Rheumatol.</i> 2013; <b>27</b>(3): 391–404. <a target=xrefwindow id=d17615e743 href="http://www.ncbi.nlm.nih.gov/pubmed/24238695">PubMed Abstract </a> | <a target=xrefwindow id=d17615e746 href="https://doi.org/10.1016/j.berh.2013.07.008">Publisher Full Text </a> | <a target=xrefwindow id=d17615e749 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3927537">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d17615e758 class=n-a></a>Hochberg MC: Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. <i>Arthritis Rheum.</i> 1997; <b>40</b>(9): 1725. <a target=xrefwindow id=d17615e766 href="http://www.ncbi.nlm.nih.gov/pubmed/9324032">PubMed Abstract </a> | <a target=xrefwindow id=d17615e769 href="https://doi.org/10.1002/art.1780400928">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718001863"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d17615e778 class=n-a></a>Petri M, Orbai A-M, Alarcón GS, <i> et al.</i>: Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. <i>Arthritis Rheum.</i> 2012; <b>64</b>(8): 2677–86. <a target=xrefwindow id=d17615e789 href="http://www.ncbi.nlm.nih.gov/pubmed/22553077">PubMed Abstract </a> | <a target=xrefwindow id=d17615e792 href="https://doi.org/10.1002/art.34473">Publisher Full Text </a> | <a target=xrefwindow id=d17615e796 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3409311">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718001863">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d17615e814 class=n-a></a>Merrill JT, Manzi S, Aranow C, <i> et al.</i>: Lupus community panel proposals for optimising clinical trials: 2018. <i>Lupus Sci Med.</i> 2018; <b>5</b>(1): e000258. <a target=xrefwindow id=d17615e825 href="http://www.ncbi.nlm.nih.gov/pubmed/29657738">PubMed Abstract </a> | <a target=xrefwindow id=d17615e828 href="https://doi.org/10.1136/lupus-2018-000258">Publisher Full Text </a> | <a target=xrefwindow id=d17615e832 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5894527">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d17615e841 class=n-a></a>Schultz HY, Dutz JP, Furukawa F, <i> et al.</i>: From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and treatments of cutaneous lupus erythematosus and dermatomyositis: a report from the 3<sup>rd</sup> International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013. <i>J Invest Dermatol.</i> 2015; <b>135</b>(1): 7–12. <a target=xrefwindow id=d17615e855 href="http://www.ncbi.nlm.nih.gov/pubmed/25501376">PubMed Abstract </a> | <a target=xrefwindow id=d17615e859 href="https://doi.org/10.1038/jid.2014.316">Publisher Full Text </a> | <a target=xrefwindow id=d17615e862 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4921244">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d17615e871 class=n-a></a>Merola JF, Nyberg F, Furukawa F, <i> et al.</i>: Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaire. <i>Lupus Sci Med.</i> 2015; <b>2</b>(1): e000085. <a target=xrefwindow id=d17615e882 href="http://www.ncbi.nlm.nih.gov/pubmed/25861460">PubMed Abstract </a> | <a target=xrefwindow id=d17615e885 href="https://doi.org/10.1136/lupus-2015-000085">Publisher Full Text </a> | <a target=xrefwindow id=d17615e889 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4379883">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d17615e899 class=n-a></a>Elman SA, Joyce C, Nyberg F, <i> et al.</i>: Development of classification criteria for discoid lupus erythematosus: Results of a Delphi exercise. <i>J Am Acad Dermatol.</i> 2017; <b>77</b>(2): 261–7. <a target=xrefwindow id=d17615e910 href="http://www.ncbi.nlm.nih.gov/pubmed/28606712">PubMed Abstract </a> | <a target=xrefwindow id=d17615e913 href="https://doi.org/10.1016/j.jaad.2017.02.030">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d17615e922 class=n-a></a>Hejazi EZ, Werth VP: Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment. <i>Am J Clin Dermatol.</i> 2016; <b>17</b>(2): 135–46. <a target=xrefwindow id=d17615e930 href="http://www.ncbi.nlm.nih.gov/pubmed/26872954">PubMed Abstract </a> | <a target=xrefwindow id=d17615e933 href="https://doi.org/10.1007/s40257-016-0173-9">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734035804"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e942 class=n-a></a>Zeidi M, Kim HJ, Werth VP: Increased Myeloid Dendritic Cells and TNF-α Expression Predicts Poor Response to Hydroxychloroquine in Cutaneous Lupus Erythematosus. <i>J Invest Dermatol.</i> 2019; <b>139</b>(2): 324–32. <a target=xrefwindow id=d17615e950 href="http://www.ncbi.nlm.nih.gov/pubmed/30227141">PubMed Abstract </a> | <a target=xrefwindow id=d17615e953 href="https://doi.org/10.1016/j.jid.2018.07.041">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734035804">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d17615e966 class=n-a></a>Robinson ES, Werth VP: The role of cytokines in the pathogenesis of cutaneous lupus erythematosus. <i>Cytokine.</i> 2015; <b>73</b>(2): 326–34. <a target=xrefwindow id=d17615e974 href="http://www.ncbi.nlm.nih.gov/pubmed/25767072">PubMed Abstract </a> | <a target=xrefwindow id=d17615e977 href="https://doi.org/10.1016/j.cyto.2015.01.031">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733663292"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e986 class=n-a></a>Sarkar MK, Hile GA, Tsoi LC, <i> et al.</i>: Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. <i>Ann Rheum Dis.</i> 2018; <b>77</b>(11): 1653–64. <a target=xrefwindow id=d17615e997 href="http://www.ncbi.nlm.nih.gov/pubmed/30021804">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1000 href="https://doi.org/10.1136/annrheumdis-2018-213197">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1004 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6185784">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733663292">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726760175"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1017 class=n-a></a>Stannard JN, Reed TJ, Myers E, <i> et al.</i>: Lupus Skin Is Primed for IL-6 Inflammatory Responses through a Keratinocyte-Mediated Autocrine Type I Interferon Loop. <i>J Invest Dermatol.</i> 2017; <b>137</b>(1): 115–22. <a target=xrefwindow id=d17615e1028 href="http://www.ncbi.nlm.nih.gov/pubmed/27646883">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1031 href="https://doi.org/10.1016/j.jid.2016.09.008">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1035 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5183476">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726760175">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d17615e1049 class=n-a></a>Braunstein I, Klein R, Okawa J, <i> et al.</i>: The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. <i>Br J Dermatol.</i> 2012; <b>166</b>(5): 971–5. <a target=xrefwindow id=d17615e1060 href="http://www.ncbi.nlm.nih.gov/pubmed/22242767">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1063 href="https://doi.org/10.1111/j.1365-2133.2012.10825.x">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1067 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3336025">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d17615e1076 class=n-a></a>Isaacson D, Elgart M, Turner ML: Anti-malarials in Dermatology. <i>Int J Dermatol.</i> 1982; <b>21</b>(7): 379–95. <a target=xrefwindow id=d17615e1084 href="http://www.ncbi.nlm.nih.gov/pubmed/6752053">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1087 href="https://doi.org/10.1111/j.1365-4362.1982.tb03155.x">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d17615e1096 class=n-a></a>Callen JP: Management of skin disease in patients with lupus erythematosus. <i>Best Pract Res Clin Rheumatol.</i> 2002; <b>16</b>(2): 245–64. <a target=xrefwindow id=d17615e1104 href="http://www.ncbi.nlm.nih.gov/pubmed/12041952">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1107 href="https://doi.org/10.1053/berh.2001.0224">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735323630"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1116 class=n-a></a>Wozniacka A, Carter A, McCauliffe DP: Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit. <i>Lupus.</i> 2016; <b>11</b>(2): 71–81. <a target=xrefwindow id=d17615e1124 href="http://www.ncbi.nlm.nih.gov/pubmed/11958581">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1127 href="https://doi.org/10.1191/0961203302lu147rr">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735323630">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731604289"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1140 class=n-a></a>Nutan F, Ortega-Loayza AG: Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options. <i>J Investig Dermatol Symp Proc.</i> 2017; <b>18</b>(2): S64–S68. <a target=xrefwindow id=d17615e1148 href="http://www.ncbi.nlm.nih.gov/pubmed/28941497">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1151 href="https://doi.org/10.1016/j.jisp.2017.02.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731604289">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d17615e1164 class=n-a></a>Alves P, Bashir MM, Wysocka M, <i> et al.</i>: Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus. <i>J Investig Dermatol Symp Proc.</i> 2017; <b>18</b>(2): S57–S63. <a target=xrefwindow id=d17615e1175 href="http://www.ncbi.nlm.nih.gov/pubmed/28941496">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1178 href="https://doi.org/10.1016/j.jisp.2016.11.001">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1182 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5645024">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727233666"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1192 class=n-a></a>Chasset F, Bouaziz JD, Costedoat-Chalumeau N, <i> et al.</i>: Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis. <i>Br J Dermatol.</i> 2017; <b>177</b>(1): 188–96. <a target=xrefwindow id=d17615e1203 href="http://www.ncbi.nlm.nih.gov/pubmed/28112801">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1206 href="https://doi.org/10.1111/bjd.15312">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727233666">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724200291"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1219 class=n-a></a>Kreuter A, Tomi NS, Weiner SM, <i> et al.</i>: Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy. <i>Br J Dermatol.</i> 2007; <b>156</b>(6): 1321–7. <a target=xrefwindow id=d17615e1230 href="http://www.ncbi.nlm.nih.gov/pubmed/17408395">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1233 href="https://doi.org/10.1111/j.1365-2133.2007.07826.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724200291">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/721060823"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1246 class=n-a></a>Gammon B, Hansen C, Costner MI: Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus. <i>J Am Acad Dermatol.</i> 2011; <b>65</b>(4): 717–721.e2. <a target=xrefwindow id=d17615e1254 href="http://www.ncbi.nlm.nih.gov/pubmed/21641078">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1257 href="https://doi.org/10.1016/j.jaad.2010.08.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/721060823">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735323631"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1270 class=n-a></a>Islam MN, Hossain M, Haq SA, <i> et al.</i>: Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus. <i>Int J Rheum Dis.</i> 2012; <b>15</b>(1): 62–8. <a target=xrefwindow id=d17615e1281 href="http://www.ncbi.nlm.nih.gov/pubmed/22324948">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1284 href="https://doi.org/10.1111/j.1756-185X.2011.01665.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735323631">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718207867"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1297 class=n-a></a>Gandhi AK, Kang J, Havens CG, <i> et al.</i>: Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4<sup>CRBN</sup>. <i>Br J Haematol.</i> 2014; <b>164</b>(6): 811–21. <a target=xrefwindow id=d17615e1311 href="http://www.ncbi.nlm.nih.gov/pubmed/24328678">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1315 href="https://doi.org/10.1111/bjh.12708">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1318 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4232904">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718207867">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d17615e1331 class=n-a></a>Housman TS, Jorizzo JL, McCarty MA, <i> et al.</i>: Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. <i>Arch Dermatol.</i> 2003; <b>139</b>(1): 50–4. <a target=xrefwindow id=d17615e1342 href="http://www.ncbi.nlm.nih.gov/pubmed/12533164">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1345 href="https://doi.org/10.1001/archderm.139.1.50">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d17615e1355 class=n-a></a>Baret I, De Haes P: Thalidomide: Still an important second-line treatment in refractory cutaneous lupus erythematosus? <i>J Dermatolog Treat.</i> 2015; <b>26</b>(2): 173–7. <a target=xrefwindow id=d17615e1363 href="http://www.ncbi.nlm.nih.gov/pubmed/24731053">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1366 href="https://doi.org/10.3109/09546634.2014.906036">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731932277"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1375 class=n-a></a>Chasset F, Tounsi T, Cesbron E, <i> et al.</i>: Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: A systematic review and meta-analysis. <i>J Am Acad Dermatol.</i> 2018; <b>78</b>(2): 342-350.e4. <a target=xrefwindow id=d17615e1386 href="http://www.ncbi.nlm.nih.gov/pubmed/28989111">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1389 href="https://doi.org/10.1016/j.jaad.2017.09.059">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731932277">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d17615e1402 class=n-a></a>Shah A, Albrecht J, Bonilla-Martinez Z, <i> et al.</i>: Lenalidomide for the treatment of resistant discoid lupus erythematosus. <i>Arch Dermatol.</i> 2009; <b>145</b>(3): 303–6. <a target=xrefwindow id=d17615e1413 href="http://www.ncbi.nlm.nih.gov/pubmed/19289762">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1416 href="https://doi.org/10.1001/archdermatol.2009.30">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1420 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2739109">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d17615e1429 class=n-a></a>Okon L, Rosenbach M, Krathen M, <i> et al.</i>: Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial. <i>J Am Acad Dermatol.</i> 2014; <b>70</b>(3): 583–4. <a target=xrefwindow id=d17615e1440 href="http://www.ncbi.nlm.nih.gov/pubmed/24528907">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1443 href="https://doi.org/10.1016/j.jaad.2013.11.007">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1447 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4333148">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717969576"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1456 class=n-a></a>Cortés-Hernández J, Ávila G, Vilardell-Tarrés M, <i> et al.</i>: Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus. <i>Arthritis Res Ther.</i> 2012; <b>14</b>(6): R265. <a target=xrefwindow id=d17615e1467 href="http://www.ncbi.nlm.nih.gov/pubmed/23217273">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1470 href="https://doi.org/10.1186/ar4111">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1474 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3674591">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717969576">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d17615e1487 class=n-a></a>Presto JK, Werth VP: Cutaneous Lupus Erythematosus: Current Treatment Options. <i>Curr Treat Option Rheumatol.</i> 2016; <b>2</b>(1): 36–48. <a target=xrefwindow id=d17615e1495 href="https://doi.org/10.1007/s40674-016-0033-z">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718010193"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1505 class=n-a></a>Cortés-Hernández J, Torres-Salido M, Castro-Marrero J, <i> et al.</i>: Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome. <i>Br J Dermatol.</i> 2012; <b>166</b>(3): 616–23. <a target=xrefwindow id=d17615e1516 href="http://www.ncbi.nlm.nih.gov/pubmed/21999437">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1519 href="https://doi.org/10.1111/j.1365-2133.2011.10693.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718010193">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d17615e1532 class=n-a></a>Yokogawa N, Tanikawa A, Amagai M, <i> et al.</i>: Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI). <i>Mod Rheumatol.</i> 2014; <b>23</b>(2): 318–22. <a target=xrefwindow id=d17615e1543 href="http://www.ncbi.nlm.nih.gov/pubmed/22581095">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1546 href="https://doi.org/10.1007/s10165-012-0656-3">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729456551"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1555 class=n-a></a>Ky C, Swasdibutra B, Khademi S, <i> et al.</i>: Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept Study. <i>Dermatol Reports.</i> 2015; <b>7</b>(1): 5804. <a target=xrefwindow id=d17615e1566 href="http://www.ncbi.nlm.nih.gov/pubmed/25918617">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1569 href="https://doi.org/10.4081/dr.2015.5804">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1573 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4387332">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729456551">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d17615e1586 class=n-a></a>Werth VP, Fiorentino D, Sullivan BA, <i> et al.</i>: Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(5): 1028–1034. <a target=xrefwindow id=d17615e1597 href="http://www.ncbi.nlm.nih.gov/pubmed/28118537">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1600 href="https://doi.org/10.1002/art.40052">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1604 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5434930">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727158446"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1613 class=n-a></a>Iaccarino L, Bettio S, Reggia R, <i> et al.</i>: Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus. <i>Arthritis Care Res (Hoboken).</i> 2017; <b>69</b>(1): 115–123. <a target=xrefwindow id=d17615e1624 href="http://www.ncbi.nlm.nih.gov/pubmed/27390293">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1627 href="https://doi.org/10.1002/acr.22971">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727158446">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726233823"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1640 class=n-a></a>Khamashta M, Merrill JT, Werth VP, <i> et al.</i>: Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study. <i>Ann Rheum Dis.</i> 2016; <b>75</b>(11): 1909–1916. <a target=xrefwindow id=d17615e1651 href="http://www.ncbi.nlm.nih.gov/pubmed/27009916">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1654 href="https://doi.org/10.1136/annrheumdis-2015-208562">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1658 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5099191">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726233823">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726989983"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1672 class=n-a></a>Furie R, Khamashta M, Merrill JT, <i> et al.</i>: Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(2): 376–386. <a target=xrefwindow id=d17615e1683 href="http://www.ncbi.nlm.nih.gov/pubmed/28130918">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1686 href="https://doi.org/10.1002/art.39962">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1690 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5299497">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726989983">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733677639"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1703 class=n-a></a>Wallace DJ, Furie RA, Tanaka Y, <i> et al.</i>: Baricitinib for systemic lupus erythematosus: A double-blind, randomised, placebo-controlled, phase 2 trial. <i>Lancet.</i> 2018; <b>392</b>(10143): 222–231. <a target=xrefwindow id=d17615e1714 href="http://www.ncbi.nlm.nih.gov/pubmed/30043749">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1717 href="https://doi.org/10.1016/S0140-6736(18)31363-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733677639">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d17615e1730 class=n-a></a>Furie R, Werth VP, Merola JF, <i> et al.</i>: Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus. <i>J Clin Invest.</i> 2019; <b>129</b>(3): 1359–1371. <a target=xrefwindow id=d17615e1741 href="http://www.ncbi.nlm.nih.gov/pubmed/30645203">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1744 href="https://doi.org/10.1172/JCI124466">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1748 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6391094">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d17615e1757 class=n-a></a>Werth VP, Furie R, Gaudy A, <i> et al.</i>: CC-220 Decreases B-Cell Subsets and Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus (SLE) Patients and Is Associated with Skin Improvement: Pharmacodynamic Results from a Phase IIa Proof of Concept Study. <i>Arthritis Rheum.</i> 2017; <b>69</b>. <a target=xrefwindow id=d17615e1768 href="https://acrabstracts.org/abstract/cc-220-decreases-b-cell-subsets-and-plasmacytoid-dendritic-cells-in-systemic-lupus-erythematosus-sle-patients-and-is-associated-with-skin-improvement-pharmacodynamic-results-from-a-phase-iia-proof/">Reference Source</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d17615e1777 class=n-a></a>Van Vollenhoven RF, Hahn BH, Tsokos GC, <i> et al.</i>: Efficacy and safety of ustekinumab, an interleukin 12/23 inhibitor, in patients with active systemic lupus erythematosus: results of a phase 2, randomized placebo-controlled study. <i>Arthritis Rheum.</i> 2017; <b>69</b>(suppl 10). <a target=xrefwindow id=d17615e1788 href="https://acrabstracts.org/abstract/efficacy-and-safety-of-ustekinumab-an-interleukin-1223-inhibitor-in-patients-with-active-systemic-lupus-erythematosus-results-of-a-phase-2-randomized-placebo-controlled-study/">Reference Source</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d17615e1797 class=n-a></a>Concha JSS, Patsatsi A, Marshak-Rothstein A, <i> et al.</i>: Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations. <i>J Invest Dermatol.</i> 2019; <b>139</b>(2): 270–6. <a target=xrefwindow id=d17615e1808 href="http://www.ncbi.nlm.nih.gov/pubmed/30243657">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1811 href="https://doi.org/10.1016/j.jid.2018.08.017">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1815 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6394859">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d17615e1825 class=n-a></a>Presto JK, Hejazi EZ, Werth VP: Biological therapies in the treatment of cutaneous lupus erythematosus. <i>Lupus.</i> 2017; <b>26</b>(2): 115–8. <a target=xrefwindow id=d17615e1833 href="http://www.ncbi.nlm.nih.gov/pubmed/27687023">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1836 href="https://doi.org/10.1177/0961203316670731">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717996303"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1845 class=n-a></a>Furie R, Petri M, Zamani O, <i> et al.</i>: A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. <i>Arthritis Rheum</i> 2011; <b>63</b>(12): 3918–30. <a target=xrefwindow id=d17615e1856 href="http://www.ncbi.nlm.nih.gov/pubmed/22127708">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1859 href="https://doi.org/10.1002/art.30613">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1863 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5007058">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717996303">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d17615e1875 class=n-a></a>Manzi S, Sánchez-Guerrero J, Merrill JT, <i> et al.</i>: Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. <i>Ann Rheum Dis.</i> 2012; <b>71</b>(11): 1833–8. <a target=xrefwindow id=d17615e1886 href="http://www.ncbi.nlm.nih.gov/pubmed/22550315">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1889 href="https://doi.org/10.1136/annrheumdis-2011-200831">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1893 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3465857">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d17615e1902 class=n-a></a>Sanz I, Yasothan U, Kirkpatrick P: Belimumab. <i>Nat Rev Drug Discov.</i> 2011; <b>10</b>(5): 335–6. <a target=xrefwindow id=d17615e1910 href="http://www.ncbi.nlm.nih.gov/pubmed/21532557">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1913 href="https://doi.org/10.1038/nrd3436">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d17615e1922 class=n-a></a>Klein R, Moghadam-Kia S, Taylor L, <i> et al.</i>: Quality of life in cutaneous lupus erythematosus. <i>J Am Acad Dermatol.</i> 2011; <b>64</b>(5): 849–58. <a target=xrefwindow id=d17615e1933 href="http://www.ncbi.nlm.nih.gov/pubmed/21397983">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1936 href="https://doi.org/10.1016/j.jaad.2010.02.008">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1940 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3079065">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735323719"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1949 class=n-a></a>Batalla A, García-Doval I, Peón G, <i> et al.</i>: A quality-of-life study of cutaneous lupus erythematosus. <i>Actas Dermosifiliogr.</i> 2013; <b>104</b>(9): 800–6. <a target=xrefwindow id=d17615e1960 href="http://www.ncbi.nlm.nih.gov/pubmed/23787361">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1963 href="https://doi.org/10.1016/j.ad.2013.04.005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735323719">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720873458"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d17615e1976 class=n-a></a>Santiago-Casas Y, Vilá LM, McGwin G Jr, <i> et al.</i>: Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. <i>Arthritis Care Res (Hoboken).</i> 2012; <b>64</b>(5): 704–12. <a target=xrefwindow id=d17615e1987 href="http://www.ncbi.nlm.nih.gov/pubmed/22190480">PubMed Abstract </a> | <a target=xrefwindow id=d17615e1990 href="https://doi.org/10.1002/acr.21581">Publisher Full Text </a> | <a target=xrefwindow id=d17615e1994 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3559016">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720873458">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Mar 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-332.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-332.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Dermatology, Corporal Michael J. Crescenz VAMC, 3900 Woodland Avenue, Philadelphia, PA 19104, USA<br/> <sup>2</sup> Department of Dermatology, Perelman Center for Advanced Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Suite 1-330A, Philadelphia, PA 19104, USA<br/> <p> <div class=margin-bottom> Kristen L. Chen <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Rebecca L. Krain <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Victoria P. Werth <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Supervision, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-332/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 25 Mar 2019, 8:332 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.17787.1">https://doi.org/10.12688/f1000research.17787.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Chen KL <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=19447 data-id=17787 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17787.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-332/v1/pdf?article_uuid=28d2c437-8ab1-4c78-881b-d125911b21c3" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.17787.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Chen KL, Krain RL and Werth VP. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus [version 1; peer review: 3 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):332 (<a href="https://doi.org/10.12688/f1000research.17787.1" target=_blank>https://doi.org/10.12688/f1000research.17787.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=17787 id=mobile-track-article-signin-17787 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17787?target=/articles/8-332.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=19447 /> <input name=articleId type=hidden value=17787 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Jan P. Dutz</strong>, Department of Dermatology and Skin Science, University of British Columbia, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>J. Michelle Kahlenberg</strong>, Division of Rheumatology, University of Michigan, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> Participated on Advisory boards for AstraZeneca. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Richard D. Sontheimer</strong>, Department of Dermatology, University of Utah School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 25 Mar 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-332.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-332.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=47924-45932></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=47923-45927></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=47925-45931></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-332/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>25 Mar 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Jan P. Dutz</strong>, Department of Dermatology and Skin Science, University of British Columbia, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>J. Michelle Kahlenberg</strong>, Division of Rheumatology, University of Michigan, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> Participated on Advisory boards for AstraZeneca. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Richard D. Sontheimer</strong>, Department of Dermatology, University of Utah School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-332.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-332/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Advancing understanding, diagnosis, and therapies...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-332/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-332/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-332/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Chen KL et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-332/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-332",
            templates : {
                twitter : "Advancing understanding, diagnosis, and therapies for cutaneous.... Chen KL et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-332/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/17787/19447")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "19447");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "45927": 1,
                           "45931": 0,
                           "45932": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "b451b97c-81df-47b1-8976-d1e0ba78e176";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-332.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-332.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-332.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-332.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-332.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>